NasdaqCM - Delayed Quote USD

HeartBeam, Inc. (BEAT)

Compare
2.2800 +0.2500 (+12.32%)
At close: September 25 at 4:00 PM EDT
2.4099 +0.13 (+5.70%)
After hours: September 25 at 7:33 PM EDT
Loading Chart for BEAT
DELL
  • Previous Close 2.0300
  • Open 2.0400
  • Bid 2.1600 x 100
  • Ask 2.3400 x 100
  • Day's Range 2.0400 - 2.4500
  • 52 Week Range 1.0600 - 3.3890
  • Volume 398,852
  • Avg. Volume 78,139
  • Market Cap (intraday) 60.562M
  • Beta (5Y Monthly) -0.99
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5600
  • Earnings Date Aug 14, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 5.00

HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

www.heartbeam.com

15

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BEAT

View More

Performance Overview: BEAT

Trailing total returns as of 9/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BEAT
2.98%
S&P 500
19.97%

1-Year Return

BEAT
5.56%
S&P 500
32.46%

3-Year Return

BEAT
57.78%
S&P 500
23.08%

5-Year Return

BEAT
57.78%
S&P 500
23.08%

Compare To: BEAT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BEAT

View More

Valuation Measures

Annual
As of 9/25/2024
  • Market Cap

    60.56M

  • Enterprise Value

    51.40M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    6.96

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -69.75%

  • Return on Equity (ttm)

    -113.62%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -16.91M

  • Diluted EPS (ttm)

    -0.5600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.16M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -6.47M

Research Analysis: BEAT

View More

Earnings Per Share

Consensus EPS
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

2.00
5.00 Average
2.2800 Current
8.00 High
 

Company Insights: BEAT

People Also Watch